Sea Lane Biotechnologies LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sea Lane Biotechnologies LLC
This Month's Profile Group: Central Venous Access: Start-Ups Change The Standard Of Care, features profiles of Bio 2 Medical, Houston Medical Robotics, and Mirador Biomedical. Plus these Start-Ups Across Health Care: BioVerys, Clinmet, Eclipse Breast Health Technologies, and Sea Lane Biotechnologies.
Sea Lane Biotechnologies LLC’s original goal was to leverage the immunological repertoire of flu epidemic survivors by harvesting bone marrow and screening for natural antibodies that could then be developed into drugs, but the human-derived antibodies that Sea Lane gathered in its early days contributed to a new technology platform. Sea Lane thinks its technology, called ConCIRT, for Contextual Immune Repertoire Technology, will prove capable of generating novel treatments for cancer and potentially other non-infectious diseases.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
- Drug Discovery Tools
- Large Molecule